Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Soft Robotic Medical Device to Benefit Patients with Heart Failure

XTALKS VITALS NEWS

Heart

The blood-free pump uses compressed air to contract along with the heart’s natural rhythm and strengthen the organ’s function.

Share this!

January 23, 2017 | by Sarah Hand, M.Sc.

A soft robotic sleeve which supports contraction of the heart muscle has been developed by researchers at Harvard University and Boston Children’s Hospital. The blood-free pump uses compressed air to contract along with the heart’s natural rhythm and strengthen the organ’s function.

Patients with heart failure are often outfitted with a left ventricular assist device (LVAD), which can prologue life. Unfortunately, these medical devices carry inherent risks, such as stroke, requiring patients to be prescribed anticoagulant drugs.

In comparison, the robotic device does not come in contact with a patient’s blood, eliminating the need for blood thinners and reducing the risk of infection. The soft robotic sleeve also doesn’t produce disruptive changes in blood flow that can lead to some of the negative side effects associated with LVADs.

The medical device is composed of silicone, and the size and fit can be adjusted on an individual basis. According to the researchers – whose article was published in the journal, Science Translational Medicine – the device could benefit patients on the transplant list who are waiting for a new heart.



“The cardiac field had turned away from idea of developing heart compression instead of blood-pumping VADs due to technological limitations, but now with advancements in soft robotics it’s time to turn back,” said Dr. Frank Pigula, a cardiothoracic surgeon, and one of the authors of the study. “Most people with heart failure do still have some function left; one day the robotic sleeve may help their heart work well enough that their quality of life can be restored.”

According to the Centers for Disease Control and Prevention (CDC), approximately 5.7 million adults in the US have heart failure. Within five years of diagnosis, around 50 percent of patients with heart failure will die of the condition.


Keywords: Medical Device, Heart Failure, Anticoagulants


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
New Self-Injectable Form of Lupus Drug Approved by the FDA

July 25, 2017 - Patients with systemic lupus erythematosus (SLE) will now have the option to self-inject their medication thanks to the FDA approval of GSK’s reformulated lupus drug, Benlysta (belimumab).

Featured In: Biotech News


Canadian Chicken Farmers to Further Reduce Use of Antibiotics

July 24, 2017 - The Chicken Farmers of Canada, a national group dedicated to supporting poultry farmers and helping them meet consumer demand for chicken, has announced their strategy for eliminating the use of certain antimicrobials in meat production.

Featured In: Food News


Neonatal MRI Medical Device Approved by the FDA

July 24, 2017 - Medical device maker Aspect Imaging has received US Food and Drug Administration (FDA) approval for its Embrace Neonatal MRI System.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets from #AAIC17

REGISTER FOR THESE WEBINARS

Into the Great Wide Open: PTC’s Transformation & Global Journey to Bring Patients a First Ever Rare Disease Therapy


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.